3D printed microfluidic devices: enablers and barriers.
By S. Waheed, Joan M. Cabot, Niall P. Macdonald, T. Lewis, R. Guijt, B. Paull, M. Breadmore. Lab on a Chip, 2016
808 citations recorded by the source corpus.
3D printing has the potential to significantly change the field of microfluidics. The ability to fabricate a complete microfluidic device in a single step from a computer model has obvious attractions, but it is the ability to create truly three dimensional structures that will provide new microfluidic capability that is challenging, if not impossible to make with existing approaches. This critical review covers the current state of 3D printing for microfluidics, focusing on the four most frequently used printing approaches: inkjet (i3DP), stereolithography (SLA), two photon polymerisation (2PP) and extrusion printing (focusing on fused deposition modeling). It discusses current achievements and limitations, and opportunities for advancement to reach 3D printing's full potential.
Subfields: Automotive Engineering, Biomedical Engineering
View Paper: https://www.semanticscholar.org/paper/81c012fa5b345767e2c6e5de5e7e00370c3a301b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Automotive Engineering
In Biomedical Engineering
Citations in the corpus
- Electrochemical biosensors for pathogen detection (2020, background): “In particular, 3D printing has emerged as a useful fabrication platform for microfluidic-based analytical platforms (Waheed et al. 2016).”
- A Review of Current Methods in Microfluidic Device Fabrication and Future Commercialization Prospects (2018, background): “Besides these conventional materials, composite materials such as reinforced polymer composites and nanocomposites can also be utilized [40].”
- Is It Time to Start Transitioning From 2D to 3D Cell Culture? (2020, background): “Furthermore, therapeutic strategies and drug development are being tested on organ-chip models that mimic organs with diseases such as thrombosis (Barrile et al., 2018), inflammatory bowel disease (Kim et al., 2016), asthma (Benam et al., 2016), and barth syndrome (Wang et al., 2014).”